Hematology

Bio-Rad’s ddPCR technology provides faster, more accurate diagnoses

Drug can affect non-Hodgkin’s lymphoma cell lines

Two different trials in prostate cancer see encouraging patient responses

NuCana announces first patients dosed in Phase 3 Acelarin (NUC-1031) study for biliary tract cancer 

LipoMedix announces publication of positive Phase 1 data for Promitil in Investigational New Drugs

Bayer enters into collaboration with Children’s Hospital of Philadelphia on novel small-molecule drugs

BioLineRx’s combination regimen leads to improved disease control in pancreatic cancer

Test that has proven useful for non-invasive colorectal cancer screening leads to new possibilities


Bavencio significantly improved overall survival in patients with locally advanced or metastatic urothelial carcinoma

Sirnaomics and Innovent collaborate to conduct clinical oncology studies combining STP705 and sintilimab in the U.S.


I-Mab Biopharma announces dosing of first patient in mainland China with TJ202/MOR202 for multiple myeloma

The EMA accepts regulatory submission for Lumoxiti in relapsed or refractory hairy cell leukemia